ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$7.99 USD
-1.00 (-11.12%)
Updated Apr 30, 2024 04:00 PM ET
After-Market: $7.86 -0.13 (-1.63%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
IBRX 7.99 -1.00(-11.12%)
Will IBRX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IBRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IBRX
Here's Why ImmunityBio (IBRX) Is a Great 'Buy the Bottom' Stock Now
ImmunityBio (IBRX)'s Technical Outlook is Bright After Key Golden Cross
IBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Qiagen (QGEN) Q3 Earnings and Revenues Surpass Estimates
Should IQ Chaikin U.S. Small Cap ETF (CSML) Be on Your Investing Radar?
FDA Rejects ImmunityBio's (IBRX) Bladder Cancer Therapy Filing
Other News for IBRX
Check Out What Whales Are Doing With IBRX
ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to Discuss ANKTIVA® Approval in Fireside Chat at the Annual Conference of the American Urological Association
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Stocks Quietly Climb Ahead Of Central Bank Storm
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday